These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 386651)

  • 21. [Enhanced effectiveness of antibiotic therapy with an exogenous lysozyme in dysentery in children].
    Vereshchagin IA; Vereshchagin SI; Zhuravleva OD
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):927-31. PubMed ID: 3936408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Humoral and cellular immunity in patients with acute dysentery].
    Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN
    Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054
    [No Abstract]   [Full Text] [Related]  

  • 23. [Passive hemagglutination tests with Shigella flexneri and Shigella sonnei antigens in the diagnosis of dysentery].
    Prokopowicz D
    Wiad Lek; 1972 Jul; 25(11):977-80. PubMed ID: 4557140
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinico-immunological characteristics of dysentery].
    Krotkova MR; Satarova AG; Favorskiĭ MS
    Sov Med; 1983; (12):38-41. PubMed ID: 6369561
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of immunoenzyme analysis in the rapid diagnosis and study of the characteristics of circulating O-antigen in biological fluids of patients with acute dysentery Sonne].
    Pak SG; Voronov AV; Gurskiĭ IuN; Malov VA; Tur'ianov MKh
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):77-81. PubMed ID: 2477971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intracellular parasitism of Shigella in patients with dysentery].
    Kolesnikova AF; Vakulin GM
    Arkh Patol; 1975; 37(5):30-4. PubMed ID: 1106366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The indirect haemagglutination test in dysentery caused by Shigella sonnei and Shigella flexneri.
    HAVLIK J; KOTT B; POTUZNIK V
    J Clin Pathol; 1959 Sep; 12(5):440-3. PubMed ID: 13852176
    [No Abstract]   [Full Text] [Related]  

  • 28. [Identification of specific antibodies in dysentery].
    Bunin KV; Belaia OF
    Sov Med; 1984; (10):19-22. PubMed ID: 6393359
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunocorrective therapy of patients with acute dysentery].
    Usychenko EM; Mashilov VP
    Lik Sprava; 1992 Jun; (6):125-6. PubMed ID: 1455821
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
    Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Test of the safety, reactogeneity and immunogeneity of live Flexner 2a and Sonne dysentery vaccine from spontaneous mutants, prepared in dragee form, in a controlled experiment on adults].
    Belaia IuA; Birkovskii IuE; Milovanova LP; Pavlova LI; Kuz'min +SN
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):20-5. PubMed ID: 320801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of a secondary immunodeficiency in the pathogenesis of different forms of dysentery].
    Usychenko EM; Mashilov VP
    Ter Arkh; 1991; 63(11):18-9. PubMed ID: 1810052
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibody against Shigella in bacillary dysentery patients and carriers. I. Sonne-dysentery].
    Miyata Y; Kitaura T; Hirakata T; Kakamura M; Sugiyama S
    Nihon Densenbyo Gakkai Zasshi; 1969 Dec; 43(9):217-24. PubMed ID: 4983206
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
    Vereshchagin IA; Zhuravleva OD
    Antibiotiki; 1984 Oct; 29(10):791-4. PubMed ID: 6439109
    [No Abstract]   [Full Text] [Related]  

  • 37. [Phagocytizing blood cells in dysentery].
    Teĭber EL; Sel'kov SA
    Sov Med; 1986; (7):21-5. PubMed ID: 3532361
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.
    Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y
    J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A comparative study of specific immunity in children at various periods of convalescence after acute Sonne dysentery].
    Ankirskaia AS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):27-30. PubMed ID: 4893973
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences among Shigella spp. in susceptibility to the bactericidal activity of human serum.
    Okamura N; Nakaya R; Suzuki K; Kondo S; Hisatsune K; Imagawa Y; Sagara H; Matsubara Y
    J Gen Microbiol; 1988 Jul; 134(7):2057-65. PubMed ID: 3246597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.